Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib with Radiation Therapy in Glioblastoma Multiforme
NCT00052208Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2002
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in glioblastoma multiforme (GBM), sponsored by National Cancer Institute. Started Mar 2002; status: completed.
02
Drugs
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00052208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00052208.